Clinical Trial Update: Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating inhaled epinephrine to attenuate systemic allergic reactions during allergy testing and oral challenges has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis
• Hypersensitivity

Drugs mentioned

• Epinephrine (inhaled) (epinephrine)

Snippet

Sponsor: Dr. George Luciuk | Conditions: Hypersensitivity, Anaphylaxis | Phase 1 | Status: COMPLETED